Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types). [electronic resource]
Producer: 20200402Description: 825-830 p. digitalISSN:- 2476-762X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Disease Progression
- Docetaxel -- administration & dosage
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Squamous Cell Carcinoma of Head and Neck -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.